395 related articles for article (PubMed ID: 24485289)
21. Management of stage I testis cancer.
Albers P
Eur Urol; 2007 Jan; 51(1):34-43; discussion 43-4. PubMed ID: 16996677
[TBL] [Abstract][Full Text] [Related]
22. Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist.
Hammerich KH; Schroeck FR; West D; Moul JW
Oncology (Williston Park); 2010 Jul; 24(8):757-60. PubMed ID: 20718257
[TBL] [Abstract][Full Text] [Related]
23. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
24. [Management of stage I nonseminomatous germ cell tumours after orchiectomy].
Culine S; ;
Prog Urol; 2004 Dec; 14(6):1112-8. PubMed ID: 15751403
[TBL] [Abstract][Full Text] [Related]
25. Management of clinical stage I nonseminomatous germ cell testicular cancer.
Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
[TBL] [Abstract][Full Text] [Related]
26. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
27. [Testicular germ-cell tumour: diagnosis and treatment].
Houlgatte A; Bauduceau O
Ann Urol (Paris); 2005 Oct; 39(5):159-69. PubMed ID: 16370168
[TBL] [Abstract][Full Text] [Related]
28. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
29. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
30. [CCAFU french national guidelines 2016-2018 on penile cancer].
Sèbe P; Ferretti L; Savoie PH; Morel-Journel N; Fléchon A; Murez T; Rocher L; Camparo P; Méjean A; Durand X
Prog Urol; 2016 Nov; 27 Suppl 1():S167-S179. PubMed ID: 27846930
[TBL] [Abstract][Full Text] [Related]
31. GPs have key role in managing men with testicular cancer.
Josephides E; Gala A; Chowdhury S
Practitioner; 2014 Apr; 258(1770):19-23, 2-3. PubMed ID: 24881168
[TBL] [Abstract][Full Text] [Related]
32. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
Barragán-Carrillo R; Mateos-Corella S; Ortiz-Hidalgo C; Izquierdo-Echavarri E; Castillejos-Molina R; Angel M; Barragan-Arteaga I; Flaig T; Bourlon MT
Oncology (Williston Park); 2021 Dec; 35(12):816-819. PubMed ID: 35088997
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and primary treatment of testicular tumor].
Kliesch S
Urologe A; 2004 Dec; 43(12):1494-9. PubMed ID: 15592706
[TBL] [Abstract][Full Text] [Related]
34. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
35. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
36. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
37. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
38. Management of advanced germ-cell tumors of the testis.
Fléchon A; Rivoire M; Droz JP
Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
[TBL] [Abstract][Full Text] [Related]
39. [Treatment strategy for stage I testicular germ cell tumor].
Nakai Y; Nagahara A; Uemura M; Takayama H; Nonomura N
Hinyokika Kiyo; 2012 Dec; 58(12):715-20. PubMed ID: 23328172
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
